Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2008
12/04/2008WO2008146839A1 Compound for organic electroluminescent device and organic electroluminescent device
12/04/2008WO2008146753A1 Therapeutic agent for cerebral infarction
12/04/2008WO2008146665A1 Material for organic electroluminescent device, organic electroluminescent device, and organic electroluminescent display device
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008WO2008145843A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145839A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145678A1 Pyrazolopyrimidinone kinase inhibitor
12/04/2008WO2008145172A1 Tri-tert-butylcarboxyphthalocyanines, uses thereof and a process for their preparation
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008094992A3 2-aminopyridine derivatives useful as kinase inhibitors
12/04/2008WO2008082887A3 Inhibitors of poly(adp-ribose)polymerase
12/04/2008US20080300263 Pyrazolo [1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
12/04/2008US20080300250 Acetylenyl-pyrazolo-pyrimidine derivatives
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008US20080300135 5-Alkyl-7-Amino-6-Heteroaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and Their Use for Controlling Harmful Fungi
12/04/2008CA2689090A1 Kinase inhibitor
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/04/2008CA2687942A1 Therapeutic agent for cerebral infarction
12/04/2008CA2687765A1 Pyrazolopyrrolidines as inhibitors of gamma secretase
12/04/2008CA2683936A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008CA2683929A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996594A2 Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996550A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
12/03/2008EP1996549A1 Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids
12/03/2008EP1699767A4 Process for the preparation of pyridopyrimidones
12/03/2008EP1327632B1 Method for producing trimer of indole derivative, and trimer of indole derivative and laminated structure thereof
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008EP1028961B3 Pleuromutilin derivatives as antimicrobials
12/03/2008CN101316849A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/03/2008CN101316848A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/03/2008CN101316847A Pyrazolo(1, 5A) pyrimidines as protein kinase inhibitors
12/03/2008CN101316846A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia
12/03/2008CN101316845A Fused bicyclic mTOR inhibitors
12/03/2008CN101316828A Method for preparing N-triazine radical ammonium salt
12/03/2008CN101316823A 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents
12/03/2008CN101314603A Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof
12/03/2008CN100439372C Porphyrin derivatives
12/03/2008CN100439371C 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the traetment of hypertension
12/03/2008CN100439365C Compounds and compositions as protein kinase inhibitors
12/03/2008CN100439338C Compositions, methods and kits pertaining to luminescent compounds
12/03/2008CN100438909C 化合物 Compound
12/02/2008US7459557 Substituted isoindole-1,3-diones
12/02/2008US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008US7459471 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459450 metabolic and eating disorders, symptoms of hepatitis C, pain, sexual dysfunction, congestive heart failure, cerebral hemorrhage, anxiety, depression, epileptic seizures, sleep disorders, migraine and allergic rhinitis.
12/02/2008US7459448 Lactam compounds useful as protein kinase inhibitors
12/02/2008US7459414 Herbicides
12/02/2008CA2372040C Imidazodiazepine derivative
12/02/2008CA2317444C N-acyl cyclic amine derivatives
11/2008
11/27/2008WO2008144750A1 Porphyrin and conductive polymer compositions for use in solid-state electronic devices
11/27/2008WO2008144507A2 Spirooxindole inhibitors of aurora kinase
11/27/2008WO2008144253A1 Protein kinase inhibitors and methods for using thereof
11/27/2008WO2008143674A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008WO2008142250A2 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate
11/27/2008WO2008141975A1 Spiroindolinone derivatives
11/27/2008WO2008141917A1 3,3-spiroindolinone derivatives
11/27/2008WO2008121742A3 Inhibitors of bruton's tyrosine kinase
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293933 Process for preparation of enantiomerically pure compounds
11/27/2008US20080293753 Novel Compounds
11/27/2008US20080293733 Axl kinase inhibitors
11/27/2008US20080293723 Spiroindolinone derivatives
11/27/2008US20080293713 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
11/27/2008US20080293697 Pyrazolo[4,3-D]Pyrimidines
11/27/2008US20080293694 New compounds
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293689 Compounds with Atypical Antipsychotic Activity
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080293674 Azinyl Imidazoazine and Azinyl Carboxamide
11/27/2008US20080293664 Non-nucleoside reverse transcriptase inhibitors
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080292561 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents
11/27/2008US20080290034 Bridged macrocyclic module compositions
11/27/2008CA2687160A1 Spiroindolinone derivatives
11/27/2008CA2686675A1 3,3-spiroindolinone derivatives
11/27/2008CA2686485A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008CA2680264A1 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate
11/26/2008EP1995248A1 Process for the production of amino alcohols by asymmetric hydrogenation
11/26/2008EP1994931A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative
11/26/2008EP1993552A2 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
11/26/2008EP1883641B1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/26/2008EP1603913B1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008CN101312978A 2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 573